The study showed that XPG Asp1104Asp genotype was associated with a decreased risk of developing lung cancer and squamous cell carcinomas of the oropharynx, larynx, and esophagus. Signifying protective effects on these malignancies. The gene discussed is ERCC5; the disease is lung carcinoma.